Sphera Funds Management Ltd. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-05 09:15 am Purchase |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Sphera Funds Management Ltd. | 7,130,625 6.390% |
6,561,912 (+1153.82%) |
Filing |
| 2023-10-10 11:15 am Purchase |
2023-09-27 | 13G | Jasper Therapeutics, Inc. JSPR |
Sphera Funds Management Ltd. | 568,713 5.130% |
568,713 (New Position) |
Filing |